Document:

ogen-ex41_719.htm

Exhibit 4.1

SEE REVERSE FOR CERTAIN Definiens CUSIP 684023 30 2 FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK WITH A PAR VALUE OF U.S. $0.001 PER SHARE IN THE CAPITAL STOCK OF 0RAGENICS, INC. transferable on the books of the Corporation by the registered holder hereof in person or by Attorney duly authorized in writing upon surrender of this certificate properly endorsed. This certificate and the shares represented hereby are subject to the laws of the State of Florida, and to the Articles of incorporation. on and Bylaws of the Corporation, as now or hereafter amended. This certificate is not valid unless countersigned by the Transfer Agent and Registrar of the Corporation. IN WITNESS WHEREOF the Corporation has caused this certificate to be signed on its behalf the facsimile signatures of its duly authorized officers and to be sealed with its corporate seal. COUNTERSIGNED: BY: CONTINENTAL STOCK TRANSFER & TRUST COMPANY NEW YORK. NY TRANSFER AGENT Number shares ORAGENICS 2 incorporated under the laws of this state of Florida common stock the certifies that: proof is the owner of dated: ORAGENICS, INC. corporate seal 2002 president authorizes officerCAREVIEW COMMUNICATIONS, INC. 10-K

 

Exhibit 10.185

 

 

ELEVENTH AMENDMENT TO

NOTE AND WARRANT PURCHASE AGREEMENT

 

This ELEVENTH
AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of March 27, 2019 (this “Amendment”), is made
by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the “Company”), and the HealthCor Parties
(as defined below) and such of the other Investors (as defined below) who are identified on Annex I attached hereto,
as holders of a majority of the shares of Common Stock issued or issuable (on an as converted basis) upon conversion of the Notes
and Warrants (collectively, the “Majority Investors”).

WITNESSETH:

WHEREAS,
the Company, HealthCor Partners Fund, L.P. (“HealthCor Partners”), HealthCor Hybrid Offshore Master Fund, L.P.
(“HealthCor Hybrid” and, together with HealthCor Partners, the “HealthCor Parties”) and certain
additional investors that purchased additional Notes and additional Warrants on February 17, 2015 (the “2015 Investors”),
additional Notes and additional Warrants on February 23, 2018 (the “February 2018 Investors”) and additional
Notes on July 13, 2018 (the “July 2018 Investors” and, together with the 2015 Investors, the February 2018
Investors and the HealthCor Parties, the “Investors”) are parties to that certain Note and Warrant Purchase
Agreement, dated as of April 21, 2011 (as amended from time to time, including without limitation pursuant to that certain Note
and Warrant Amendment Agreement dated December 30, 2011, that certain Second Amendment to Note and Warrant Purchase Agreement dated
January 31, 2012, that certain Third Amendment to Note and Warrant Purchase Agreement dated August 20, 2013, that certain Fourth
Amendment to Note and Warrant Purchase Agreement dated January 16, 2014, that certain Fifth Amendment to Note and Warrant Purchase
Agreement dated December 15, 2014, that certain Sixth Amendment to Note and Warrant Purchase Agreement dated March 31, 2015, that
certain Seventh Amendment to Note and Warrant Purchase Agreement dated June 26, 2015, that certain Eighth Amendment to Note and
Warrant Purchase Agreement dated February 23, 2018, that certain Ninth Amendment to Note and Warrant Purchase Agreement dated July
10, 2018 and that certain Tenth Amendment to Note and Warrant Purchase Agreement dated July 13, 2018, the “Purchase Agreement”);

WHEREAS, as
contemplated by the Purchase Agreement, the Company issued and sold (a) $20,000,000 initial principal amount of Notes (the
“2011 Notes”) and Warrants to purchase 11,782,859 shares of Common Stock (the “2011 Warrants”)
to the HealthCor Parties on April 21, 2011, (b) $5,000,000 initial principal amount of Supplemental Closing Notes (the
“2012 Notes”) to the HealthCor Parties on January 31, 2012, (c) $5,000,000 initial principal amount of
2014 Supplemental Closing Notes and 2014 Supplemental Warrants to purchase 4,000,000 shares of Common Stock to the HealthCor Parties
on January 16, 2014, (d) $6,000,000 initial principal amount of Fifth Amendment Supplemental Closing Notes and Fifth Amendment
Supplemental Warrants to purchase 3,692,308 shares of Common Stock to HealthCor Partners and the 2015 Investors on February 17,
2015, (e) $2,050,000 initial principal amount of Eighth Amendment Supplemental Notes and Eighth Amendment Supplemental Warrants
to purchase 512,500 shares of Common Stock to the February 2018 Investors on February 23, 2018 and (f) $1,000,000 initial
principal amount of Tenth Amendment Supplemental Notes to the July 2018 Investors on July 13, 2018; and

    	 	1	 

    	 

    

 

WHEREAS,
pursuant to Section 7.9 of the Purchase Agreement and subject to the terms and conditions contained herein, the parties hereto
desire to (i) amend the Purchase Agreement as set forth herein for the purposes of eliminating the minimum cash balance requirement
set forth in Section 5.3 thereof and (ii) waive any breaches by the Company of Section 5.3 of the Purchase Agreement
that have occurred on or prior to the date of this Agreement.

NOW, THEREFORE,
in consideration of the mutual promises, representations, warranties and covenants contained herein and in the Purchase Agreement,
which represent integral components of the transactions contemplated hereby and thereby and shall be fully enforceable by the parties
hereto and thereto, and for other good and valuable consideration, the receipt and sufficiency of which hereby acknowledged, the
Company and the Majority Investors mutually agree as follows:

1.                 
Definitions. Capitalized terms used in this Amendment but not defined in this Amendment shall have the meanings ascribed
to them in the Purchase Agreement.

2.                 
Amendment to Purchase Agreement. Section 5.3 of the Purchase Agreement is hereby amended and restated in its
entirety to read as follows:

“[Reserved.]”

3.                 
Waiver. The parties hereto agree and acknowledge that (i) the covenants set forth in Section 5.3 of the
Purchase Agreement were intended to benefit the Investors and (ii) the Company has at certain times been in breach of Section 5.3
of the Purchase Agreement. The Majority Investors hereby waive in full any breaches by the Company of Section 5.3 of the Purchase
Agreement that have occurred on or prior to the date of this Agreement.

4.                 
No Further Amendments. Except as amended by this Amendment, the Purchase Agreement shall remain in full force and
effect in accordance with its terms.

5.                 
Miscellaneous.

(a)              
Ratification and Confirmation. The Company acknowledges, agrees and confirms that: (x) the Purchase Agreement
and each of the other Transaction Documents, as amended and otherwise modified by the amendments and other modifications specifically
provided herein or contemplated hereby, are and shall continue to be in full force and effect and are hereby in all respects ratified
and confirmed; and (y) without limiting the generality of the foregoing clause (x), all obligations, liabilities and
Indebtedness of the Company under the Transaction Documents, as amended hereby, constitute “Obligations” (as defined
in the Security Agreement) secured by and entitled to the benefits of the security set forth in the Security Agreement and the
IP Security Agreement, and the liens and security interests granted in favor of the Investors under the terms of the Security Agreement
and the IP Security Agreement are and remain perfected, effective, enforceable and valid and such liens and security interests
are, in each case, a first priority lien and security interest (except to the extent otherwise expressly permitted by the Transaction
Documents) and such liens and security interests are hereby in all respects ratified and confirmed.

    	 	2	 

    	 

    

 

(b)              
Expenses. The Company will pay and bear full responsibility for the reasonable legal fees and other out-of-pocket
costs and expenses of the Majority Investors attributable to the negotiation and consummation of the transactions contemplated
hereby.

(c)              
Further Assurances. The Company shall duly execute and deliver, or cause to be duly executed and delivered, at its
own cost and expense, such further instruments and documents and take all such action, in each case as may be necessary or proper
in the reasonable judgment of the Majority Investors to carry out the provisions and purposes of this Amendment.

(d)              
Survival. The representations, warranties, covenants and agreements made herein shall survive any investigation made
by any party hereto, and the execution and delivery of this Amendment.

(e)              
Governing Law. All questions concerning the construction, interpretation and validity of this Amendment shall be
governed by and construed and enforced in accordance with the domestic laws of the State of Delaware without giving effect to any
choice or conflict of law provision or rule (whether in the State of Delaware or any other jurisdiction) that would cause the application
of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State
of Delaware will control the interpretation and construction of this Amendment, even if under such jurisdiction’s choice
of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply.

(f)               
Construction. The Company and the Majority Investors acknowledge that the Company and its independent counsel and
the Majority Investors and their independent counsel have jointly reviewed and drafted this document, and agree that any rule of
construction and interpretation to the effect that drafting ambiguities are to be resolved against the drafting party shall not
be employed.

(g)              
Counterparts; Facsimile and Electronic Signatures. This Amendment may be executed in any number of counterparts,
and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute
but one agreement. Counterpart signatures to this Amendment delivered by facsimile or other electronic transmission shall be acceptable
and binding.

(h)              
Headings. The section and paragraph headings contained in this Amendment are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Amendment.

[Signature Pages Follow]

    	 	3	 

    	 

    

 

IN WITNESS WHEREOF,
each of the undersigned has duly executed this Eleventh Amendment to Note and Warrant Purchase Agreement as of the date first written
above.

 

	 	COMPANY:
	 	 	 
	 	CareView Communications, Inc., a Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	 	Name: Steven G. Johnson
	 	 	Title: President

 

 

 

[Signature Page to Eleventh Amendment
to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

 

	 	MAJORITY INVESTORS:
	 	 	 
	 	HealthCor Partners Fund, L.P.
	 	By: HealthCor Partners Management L.P., as Manager
	 	By: HealthCor Partners Management, G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Jeffrey C. Lightcap
	 	Name: Jeffrey C. Lightcap
	 	Title: Senior Managing Director
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 	 
	 	 
	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By: HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Joseph P. Healey
	 	Name: Joseph P. Healey
	 	Title: Trustee
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 
	 	 
	 	 	 	 

 

[Signature Page to
Eleventh Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

	 	MAJORITY INVESTORS:
	 	 
	 	 
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	 
	 	 
	 	/s/ Dr. James R. Higgins
	 	Dr. James R. Higgins
	 	 
	 	 
	 	/s/ Steven G. Johnson
	 	Steven G. Johnson
	 	 
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey C. Lightcap
	 	 

 

[Signature Page to Eleventh Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

ACKNOWLEDGED AND AGREED:

 

	CareView Communications, Inc., a Texas corporation	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	 Steven G. Johnson	 
	Title: 	 President	 
	 	 	 
	 	 	 
	CareView Operations, LLC	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	 Steven G. Johnson	 
	Title: 	 President	 

 

 

[Signature Page to Eleventh Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

Annex I

 

Investors

 

	Investors Comprising (together with HealthCor Partners Fund, L.P. and HealthCor Hybrid Offshore Master Fund, L.P.) the Majority Investors:
	Steven B. Epstein
	Dr. James R. Higgins
	Steven G. Johnson
	Jeffrey C. Lightcap

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]